Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.72 in the prior trading day, Mereo Biopharma Group Plc ADR (NASDAQ: MREO) closed at $3.76, up 1.08%. In other words, the price has increased by $1.08 from its previous closing price. On the day, 0.88 million shares were traded. MREO stock price reached its highest trading level at $3.76 during the session, while it also had its lowest trading level at $3.64.
Ratios:
Our goal is to gain a better understanding of MREO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.86 and its Current Ratio is at 4.86. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Robert W. Baird on June 13, 2024, initiated with a Outperform rating and assigned the stock a target price of $8.
On August 12, 2022, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $4.Cantor Fitzgerald initiated its Overweight rating on August 12, 2022, with a $4 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 26 ’24 when Scots-Knight Denise sold 92,273 shares for $3.39 per share. The transaction valued at 313,101 led to the insider holds 709,518 shares of the business.
Sermon Charles sold 32,187 shares of MREO for $109,217 on Jun 26 ’24. The General Counsel now owns 184,387 shares after completing the transaction at $3.39 per share. On Jun 26 ’24, another insider, Fox Christine Ann, who serves as the Chief Financial Officer of the company, sold 29,439 shares for $3.39 each. As a result, the insider received 99,892 and left with 57,571 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MREO now has a Market Capitalization of 578487232 and an Enterprise Value of 2589833472. For the stock, the TTM Price-to-Sale (P/S) ratio is 60.00 while its Price-to-Book (P/B) ratio in mrq is 12.31. Its current Enterprise Value per Revenue stands at 258.983 whereas that against EBITDA is -103.432.
Stock Price History:
Over the past 52 weeks, MREO has reached a high of $4.50, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is -1.12%, while the 200-Day Moving Average is calculated to be 20.82%.
Shares Statistics:
The stock has traded on average 1.10M shares per day over the past 3-months and 934700 shares per day over the last 10 days, according to various share statistics. A total of 140.27M shares are outstanding, with a floating share count of 140.27M. Insiders hold about 0.00% of the company’s shares, while institutions hold 62.54% stake in the company. Shares short for MREO as of 1722384000 were 4373431 with a Short Ratio of 3.99, compared to 1719532800 on 2923349. Therefore, it implies a Short% of Shares Outstanding of 4373431 and a Short% of Float of 3.4000000000000004.
